Jm. Findlay et Gm. Deagle, CAUSES OF MORBIDITY AND MORTALITY FOLLOWING INTRACRANIAL ANEURYSM RUPTURE, Canadian journal of neurological sciences, 25(3), 1998, pp. 209-215
Objective: To determine the current recovery rates and causes for morb
idity and mortality in patients suffering aneurysmal subarachnoid hemo
rrhage (SAH). Methods: We reviewed a recent consecutive series of 95 p
atients with ruptured intracranial aneurysms who presented to our hosp
ital between 1994 and 1995. When administered, active treatment consis
ted of early surgery for aneurysm clipping and aggressive prevention a
nd treatment of SAH-related complications. Results: Eighty-eight (93%)
of the patients were admitted within 24 hours of rupture. One-quarter
of the patients in this series did not undergo aneurysm clippings due
to poor neurological condition on presentation. Of the 75 patients in
itially considered for active treatment, 83% underwent surgery within
48 hours of rupture, all received nimodipine, 16% received tissue plas
minogen activator to lyse subarachnoid or intraventricular clots, 40%
underwent hypertensive treatment, and 7% underwent transluminal balloo
n angioplasty for vasospasm. At one year followup, 29% of patients had
died, 7% had severe disabilities, 13% had moderate disabilities, 51%
had made a good recovery, and 64% of all surviving patients had return
ed to their previous work status. Primary and contributing causes of d
eath and disability, affecting 47 patients at one year, were: direct e
ffects of the initial hemorrhage (79% of affected patients), surgical
complications (13%), vasospasm (11%), rebleeding (11%) and medical com
plications (13%). Conclusions: Almost two-thirds of patients suffering
aneurysm rupture make a satisfactory recovery with modem treatment. W
hile vasospasm has become a less common cause of poor outcome followin
g SAH, surgical complications remain an important problem.